TFS Capital’s Psychemedics Corporation PMD Stock Holding History

TFS Capital’s Portfolio PMD Stock Details PMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-14,020	Closed	-$350K	–	383
2017 Q2	$350K	Buy	+14,020	New	+$295K	0.14%	297

Other funds holding PMD

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Moors & Cabot Boston, Massachusetts $2.34B AUM 30.42% 1-Year Est. Return

TCM

Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIC

Crawford Investment Counsel Atlanta, Georgia $5.85B AUM 12.61% 1-Year Est. Return

UIC

Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

TFS Capital's PMD Position: Q3 2017 in Review

TFS Capital sold out of Psychemedics Corporation (PMD) in Q3 2017, closing a stake of 14,020 shares — an estimated $350K sold.

TFS Capital first reported a position in PMD in Q2 2017 and held it in 1 quarter. The position peaked at $350K in Q2 2017. 51 funds tracked by Wall St. Rank hold PMD as of Q3 2017.

TFS Capital reported no remaining Psychemedics Corporation position as of Q3 2017 after selling out during the quarter.
TFS Capital sold 14,020 Psychemedics Corporation shares in Q3 2017, an estimated $350K.
TFS Capital first reported a position in Psychemedics Corporation in Q2 2017 and held it in 1 quarter.
TFS Capital's Psychemedics Corporation position peaked at $350K in Q2 2017.
51 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q3 2017.

Based on TFS Capital's 13F filing for Q3 2017.